SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 1674.08 millions for the March 2025 quarter. The mentioned figure indicates a growth of about 41.83% as compared to Rs. 1180.33 millions during the year-ago period.A comparatively good net profit growth of 39.68% to Rs. 70.72 millions was reported for the quarter ended March 2025 compared to Rs. 50.63 millions of previous same quarter.The company reported a good operating profit of 174.39 millions compared to 111.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1674.08 1180.33 41.83 4562.68 3490.72 30.71 4562.68 3490.72 30.71
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 174.39 111.67 56.17 550.97 388.98 41.64 550.97 388.98 41.64
Interest 81.47 43.72 86.34 223.77 136.50 63.93 223.77 136.50 63.93
PBDT 92.92 67.95 36.75 327.20 252.48 29.59 327.20 252.48 29.59
Depreciation 12.50 9.56 30.75 44.49 37.96 17.20 44.49 37.96 17.20
PBT 80.42 58.39 37.73 282.71 214.52 31.79 282.71 214.52 31.79
TAX 9.70 7.76 25.00 74.63 58.28 28.05 74.63 58.28 28.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 70.72 50.63 39.68 208.08 156.24 33.18 208.08 156.24 33.18
Equity 47.22 46.99 0.49 47.22 46.99 0.49 47.22 46.99 0.49
PBIDTM(%) 10.42 9.46 10.11 12.08 11.14 8.37 12.08 11.14 8.37

Fredun Pharma Share Price

2043.90 -23.80 (-1.15%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×